Latest Tourism News

Zeotech Limited has extended its offtake agreement with Jiangsu Mineral Sources International Trading Co. to April 2027, while completing a major drilling campaign and securing key environmental and infrastructure approvals at the Toondoon Kaolin Project.

Orthocell has secured a strategic foothold in Thailand's $84 million nerve repair sector by appointing MediTime as exclusive Remplir distributor, leveraging established clinical networks to accelerate market penetration.

Tourism Holdings Limited has received a fresh non-binding indicative offer from a credible strategic buyer at NZ$3.30 to NZ$3.40 per share, while continuing negotiations with the BGH Consortium over due diligence access.

ABx Group and Good Importing International are progressing their bauxite projects in Queensland and New South Wales, with environmental approvals on track and significant investments underway.

Tourism Holdings Limited has allowed the BGH-led consortium to conduct due diligence after a revised all-cash offer of NZ$3.10 per share. The Board remains cautious, with no recommendation or decision yet on the potential acquisition.

Savannah Goldfields is edging closer to resuming mining at its Agate Creek project, awaiting a key environmental approval expected by mid-July. Early site works are underway, while gold production continues from alternative sources at the Georgetown plant.

4DMedical has leapfrogged into the European lung health market by acquiring Austrian AI imaging firm contextflow, gaining immediate commercial presence and a CE-marked lung cancer screening solution.

Tourism Holdings Limited (THL) has received a revised acquisition proposal from a BGH-led consortium offering NZ$3.10 per share. Meanwhile, THL has downgraded its FY26 profit guidance and raised its net debt forecast amid ongoing global travel uncertainties.

Experience Co posted a slight decline in Q3 FY26 revenue and underlying EBITDA, weighed down by adverse weather, industrial action, and inflationary pressures, while advancing cost reductions and strategic reviews.

Osteopore has secured Hainan FDA approval to clinically use and sell its custom orthopaedic devices at Shanghai Ruijin Hospital’s Hainan branch, marking a key step towards wider China market access. The company has scheduled its first patient surgery for June 2026.

Vection Technologies has secured approximately $1.1 million in new orders for FY26, including a $572k extension with a classified defence partner supported by Dell Technologies and $513k in Algho AI platform contracts across four enterprise sectors.

Napier Port reported a robust half-year performance with an 8.8% revenue rise to NZ$84.9 million and underlying net profit after tax up 21.5%, driven by container services growth and key infrastructure projects progressing on schedule.